Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biogen Inc. (BIIB) had Revenue of $2.45B for the most recently reported fiscal quarter, ending 2024-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$2.45B
Net Income	$266.70M
Cost of Goods Sold	$583.50M
Gross Profit	$1.87B
Operating Expenses	$2.01B
Operating Income	$441.40M
Non-Operating Income/Expense	$-149.90M
Pre-Tax Income	$291.50M
Normalized Pre-Tax Income	$291.50M
Income after Taxes	$266.70M
Income from Continuous Operations	$266.70M
Consolidated Net Income/Loss	$266.70M
Normalized Income after Taxes	$266.70M
EBIT	$441.40M
EBITDA	$710.30M
Weighted-Average Shares Outstanding (Basic)	145.60M
Weighted-Average Shares Outstanding (Diluted)	145.90M
Earnings per Share (EPS) (Basic)	$1.82
Earnings per Share (EPS) (Diluted)	$1.82
Balance Sheet Financials
Current Assets	$7.46B
Property, Plant, and Equipment	$3.18B
Long-Term Assets	$20.59B
Total Assets	$28.05B
Current Liabilities	$5.53B
Long-Term Debt	$4.55B
Long-Term Liabilities	$5.80B
Total Liabilities	$11.33B
Common Equity	$16.72B
Tangible Shareholders Equity	$545.90M
Shareholders Equity	$16.72B
Common Shares Outstanding	145.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.88B
Cash Flow from Investing Activities	$-799.20M
Cash Flow from Financial Activities	$-683.50M
Beginning Cash	$1.05B
End Cash	$2.38B
Increase/Decrease in Cash	$1.33B
Stock-Based Compensation	$291.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.38
Gross Margin	76.23%
Operating Margin	17.98%
EBIT Margin	17.98%
EBITDA Margin	--
Pre-Tax Profit Margin	11.88%
Profit Margin	10.86%
Free Cash Flow	$2.72B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.24
Receiveable Turnover	1.75
Days Sales in Receivables	51.51
Return on Equity	1.60%
Return on Tangible Equity	48.86%
Return on Assets	0.95%
Return on Investments	1.25%
Book Value Per Share	$114.73
Free Cash Flow per Share	$18.66
Operating Cash Flow per Share	$19.71

Data from Zacks Investment Research, Inc.